NCT01669070: A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) |
|
|
| Completed | 1 | 36 | Europe | FF, 50 mcg, FF, 100 mcg, FF, 200 mcg, FF, 250 mcg | GlaxoSmithKline | Asthma | 11/12 | 11/12 | | |
